Harold W. Holloway

Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer β-amyloid peptide in rodent

Nigel H. Greig, Tadanobu Utsuki, Donald K. Ingram et al. · Proceedings of the National Academy of Sciences · 2005 · 723 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism

Yazhou Li, TracyAnn Perry, Mark S. Kindy et al. · Proceedings of the National Academy of Sciences · 2009 · 576 citations · Full text

Life Sciences, Neuroscience, Pharmacology +16

A New Therapeutic Target in Alzheimer's Disease Treatment: Attention to Butyrylcholinesterase

Nigel H. Greig, Tada Utsuki, Qian‐sheng Yu et al. · Current Medical Research and Opinion · 2001 · 411 citations

Medicine, Neuroscience, Pharmacology +14

GLP-1 Receptor Stimulation Reduces Amyloid-β Peptide Accumulation and Cytotoxicity in Cellular and Animal Models of Alzheimer's Disease

Yazhou Li, Kara B. Duffy, Mary Ann Ottinger et al. · Journal of Alzheimer s Disease · 2010 · 324 citations

Medicine, Endocrinology, Neuroscience +17

Exendin-4 Decelerates Food Intake, Weight Gain, and Fat Deposition in Zucker Rats

Margarzata Szayna, Maı̀re E. Doyle, Jennifer A. Betkey et al. · Endocrinology · 2000 · 292 citations · Full text

Medicine, Animal Sciences, Endocrinology +17